Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · IEX Real-Time Price · USD
8.70
0.00 (0.00%)
At close: Jul 26, 2024, 4:00 PM
8.48
-0.22 (-2.53%)
After-hours: Jul 26, 2024, 5:27 PM EDT
Delcath Systems Revenue
Delcath Systems had revenue of $3.14M in the quarter ending March 31, 2024, with 425.80% growth. This brings the company's revenue in the last twelve months to $4.61M, up 56.81% year-over-year. In the year 2023, Delcath Systems had annual revenue of $2.07M, down -24.05%.
Revenue (ttm)
$4.61M
Revenue Growth
+56.81%
P/S Ratio
52.47
Revenue / Employee
$60,618
Employees
76
Market Cap
241.74M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
Dec 31, 2020 | 1.65M | 66.00K | 4.18% |
Dec 31, 2019 | 1.58M | -1.83M | -53.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NeuroPace | 69.07M |
Semler Scientific | 65.88M |
bluebird bio | 21.73M |
Cibus | 2.32M |
Actinium Pharmaceuticals | 81.00K |
DCTH News
- 4 days ago - Delcath Systems to Host Second Quarter 2024 Earnings Call - Business Wire
- 2 months ago - Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors - Business Wire
- 2 months ago - Delcath Systems Reports First Quarter 2024 Results and Business Highlights - PRNewsWire
- 2 months ago - Delcath Systems to Host First Quarter 2024 Earnings Call - PRNewsWire
- 2 months ago - Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT - PRNewsWire
- 3 months ago - Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 months ago - Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 months ago - Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update - PRNewsWire